Trial
NCT01755520
Study Comparing Ticagrelor With Aspirin for Prevention of Vascular Events in Patients Undergoing CABG
Phase IIITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Deutsches Herzzentrum Muenchen
Collaborators
AstraZeneca
Condition
Coronary Artery Disease
Intervention
Ticagrelor
Why stopped
DSMB Interim Analyses
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-08-02